Read More Pharma Industry News Is this the biomarker breakthrough Longeveron Inc. needs to reach Phase 3? Can biomarker-linked response boost laromestrocel’s Phase 3 prospects? Explore regulatory, financial, and industry implications. bySoujanya RaviFebruary 28, 2026